South Korea Type 1 Diabetes (T1D) Market was valued at USD 0.9 Billion in 2022 and is projected to reach USD 2.3 Billion by 2030, growing at a CAGR of 12.4% from 2024 to 2030.
The South Korea Type 1 Diabetes (T1D) market is experiencing significant growth as the number of individuals diagnosed with the condition increases. Type 1 diabetes is an autoimmune disorder that typically emerges in childhood or early adulthood, and managing this chronic condition requires continuous care, including insulin therapy and regular monitoring of blood glucose levels. With South Korea's aging population and increasing lifestyle-related health concerns, the demand for Type 1 Diabetes (T1D) products and solutions is at an all-time high.
The Type 1 Diabetes (T1D) market in South Korea is expected to see continued growth due to the increasing awareness of the disease and the availability of advanced medical treatments. Insulin pumps, continuous glucose monitoring (CGM) systems, and rapid-acting insulins are becoming essential tools in the daily management of Type 1 diabetes. Furthermore, pharmaceutical companies are working on creating innovative therapies and insulin formulations that offer better efficacy and convenience for patients.
From an industry standpoint, South Korea’s healthcare market is evolving to meet the growing needs of individuals with Type 1 Diabetes (T1D). There is a pressing requirement for greater access to diabetes management technologies, healthcare professionals who specialize in diabetes care, and educational programs that help individuals better understand their condition. The country's government and healthcare providers are increasingly focused on improving the quality of care available to individuals with Type 1 diabetes, providing more resources for research and patient education.
South Korea's robust healthcare infrastructure, coupled with strong government policies aimed at improving public health, plays a significant role in shaping the demand for diabetes management products. The country is home to several leading pharmaceutical and medical device manufacturers, which are crucial in supplying insulin pumps, syringes, and CGM devices to meet the needs of Type 1 diabetes patients. Additionally, many global players are entering the South Korean market due to its favorable regulatory environment and increasing patient base.
The industry is also focusing on the integration of artificial intelligence and data analytics into diabetes care, which is expected to further revolutionize the Type 1 Diabetes (T1D) market in South Korea. The use of AI in predictive analytics for blood glucose monitoring and management is a game-changer, making it easier for patients to monitor their condition with minimal effort. As the demand for these technologies grows, the market continues to attract investments from various sectors, signaling a bright future for diabetes care in South Korea.
Get an In-Depth Research Analysis of the South Korea Type 1 Diabetes (T1D) Market Size And Forecast [2025-2032]
Â
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Type 1 Diabetes (T1D) Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Type 1 Diabetes (T1D) Market
Insulin Therapy
Non-Insulin Therapy
Continuous Glucose Monitoring (CGM)
Insulin Pumps
Pediatric (0-18 years)
Young Adults (19-30 years)
Adults (31-60 years)
Seniors (61+ years)
Devices
Pharmaceuticals
Diabetes Management Software
Homecare Settings
Hospitals
Clinical Laboratories
Research Institutes
Type 1 Diabetes (T1D)
Latent Autoimmune Diabetes in Adults (LADA)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Type 1 Diabetes (T1D) Market Research Analysis
1. Introduction of the South Korea Type 1 Diabetes (T1D) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Type 1 Diabetes (T1D) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Type 1 Diabetes (T1D) Market, By Type
6. South Korea Type 1 Diabetes (T1D) Market, By Application
7. South Korea Type 1 Diabetes (T1D) Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Type 1 Diabetes (T1D) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/